FDA Dextromethorphan Advisory Marks Growing Concern Over Abuse
This article was originally published in The Tan Sheet
Executive Summary
An FDA "Talk Paper" is raising the profile of dextromethorphan (DXM) abuse issues from a peripheral concern to a visible public health problem